Search results for N-terminal

Anti-SLC12A1/NKCC2 antibody - N-terminal, Abcam, AB191315

Anti-SLC34A2 antibody [SP322] - N-terminal, Abcam, AB228474

What is this antibody validated in? Anti-SLC34A2 antibody [SP322] - N-terminal (ab228474) is a rabbit recombinant monoclonal antibody and is validated for use in Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF), Multiplex IHC (mIHC) in Human samples. Collaboration Anti-SLC34A2 [SP322] - N-terminal (ab228474) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC). Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies. Other related products We have a range of other formats of antibody clone [SP322] also available for your convenience: ab228474, Carrier free - ab238793 , Alexa Fluor® 488 - ab315178 , Alexa Fluor® 647 - ab315179 , PE - ab322453

Anti-SnoN/SNO antibody - N-terminal, Abcam, AB189653

Anti-ZEB1 antibody [OTI3G6] - N-terminal, Abcam, AB180905

Dilute in PBS (pH7.3) if necessary. The clone number has been updated from 3G6 to OTI3G6, both clone numbers name the same clone. This product was changed from ascites to tissue culture supernatant on 6 th September 2018. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Anti-ATG16L1 antibody [EPR15638] - N-terminal, Abcam, AB187671

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-ATP1A3 antibody [EPR14137] - N-terminal, Abcam, AB182572

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-BACH1/BRIP1 antibody - N-terminal, Abcam, AB151509

Anti-GPCR GPR103 antibody - N-terminal, Abcam, AB188976

Anti-GPCR GPR14 antibody - N-terminal, Abcam, AB150584

Anti-GPCR GPR87 antibody - N-terminal, Abcam, AB140763

Aliquot and store undiluted at -20°C or below for up to 1 year. Can be stored undiluted at 4°C for up to 1 month.